marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-12-2024
Dyne Therapeutics Financial Ratios 2011-2024 | DYN
Annual Financial Ratios Dyne Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-6.7 | -4.9 | -3.0 | -2.3 | - | - | 26.2 | -1.0 | 29.6 | -51.4 | -5.9 | 23.2 | - |
P/S |
- | - | - | - | - | - | 3.9 | 0.9 | 1.8 | 2.3 | 704.0 | 673.3 | - |
EPS |
-4.0 | -3.2 | -2.9 | -4.1 | -6.1 | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
1.53 B | 697 M | 299 M | -156 M | 2.4 M | 13.1 M | 9.87 B | 11 B | 8.62 B | 8.21 B | 3.08 B | 4.05 B | 3.02 B |
EBITDA per Share |
-3.91 | -3.04 | -2.89 | -8.37 | - | - | - | - | - | - | - | 7.4 | - |
EV/EBITDA |
-1.8 | 2.9 | - | - | 22.1 | 66.6 | 12.2 | -333.8 | 21.9 | 4.2 | - | ||
PEG |
- | 0.01 | - | - | 0.25 | 0.0 | 0.17 | -0.6 | 0.01 | 0.22 | - | ||
P/B |
17.3 | 3.2 | 1.2 | 0.4 | - | - | 1.0 | 0.6 | 0.5 | 1.1 | 1.0 | 0.8 | - |
P/CF |
-8.4 | -5.3 | -3.7 | -2.8 | - | - | 5.5 | 3.4 | -8.2 | -55.5 | 27.4 | -45.9 | - |
ROE % |
-258.44 | -66.61 | -40.55 | -17.36 | - | - | 4.00 | -60.72 | 1.71 | -2.22 | -16.11 | 3.48 | - |
ROA % |
-142.92 | -54.88 | -35.07 | -16.82 | - | - | 0.65 | -9.50 | 0.43 | -0.60 | -6.73 | 1.92 | - |
ROCE % |
-265.26 | -67.74 | -40.75 | -17.13 | - | - | -3.84 | -5.27 | 0.60 | -3.01 | -6.96 | 17.05 | - |
Current Ratio |
2.2 | 5.7 | 7.4 | 31.8 | - | - | 1.5 | 3.3 | 2.4 | 3.9 | 2.3 | 3.0 | - |
DSO |
- | - | - | - | - | - | 370.0 | 103.1 | 174.3 | 67.2 | 51100.0 | 13140.0 | - |
DIO |
- | - | - | - | - | - | 55.4 | 71.2 | 107.4 | 66.3 | 57.7 | 137.6 | - |
DPO |
- | - | - | - | - | - | 45.7 | 53.1 | 52.6 | 68.9 | 104.9 | 152.5 | - |
Operating Cycle |
- | - | - | - | - | - | 425.4 | 174.3 | 281.7 | 133.5 | 51157.7 | 13277.6 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | 379.8 | 121.2 | 229.2 | 64.7 | 51052.8 | 13125.0 | - |
All numbers in USD currency
Quarterly Financial Ratios Dyne Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.7 | -0.81 | - | -0.99 | -1.08 | -0.78 | - | -0.8 | -1.01 | -0.69 | - | -0.83 | -0.58 | -0.5 | - | -2.01 | -3.31 | -0.9 | - | -2.36 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.71 | -0.79 | - | -1.01 | -1.09 | -0.77 | - | -0.81 | - | -0.69 | - | -0.83 | -0.59 | -0.5 | - | -1.92 | -3.13 | -0.88 | - | -1.42 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-101.33 | -124.31 | -89.24 | -105.81 | -82.78 | -69.63 | -45.37 | -55.65 | -49.36 | -37.76 | -22.12 | -26.19 | -19.97 | -15.98 | -8.99 | -115.15 | -217.24 | -196.91 | -58.49 | -58.49 | 47.67 | 29.97 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-79.12 | -97.06 | -70.46 | -84.27 | -68.74 | -52.10 | -32.16 | -41.28 | -27.42 | -33.83 | -20.61 | -24.55 | -19.37 | -15.50 | -8.71 | -99.37 | -186.08 | -183.54 | -90.65 | -90.65 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-105.67 | -128.64 | -92.01 | -108.94 | -84.91 | -71.03 | -45.94 | -56.27 | -49.67 | -37.95 | -22.25 | -26.20 | -19.82 | -15.69 | -8.78 | -34.63 | -56.54 | -54.00 | -25.85 | -25.85 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
16.3 | 11.8 | 2.2 | 3.9 | 5.6 | 6.2 | 5.7 | 6.0 | - | 7.6 | 7.4 | 8.8 | 32.1 | 36.6 | 32.2 | 32.2 | 32.2 | 32.2 | 6.8 | 6.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency